Cargando…
Flecainide is well-tolerated and effective in patient with atrial fibrillation at 12 months: a retrospective study
INTRODUCTION: Current atrial fibrillation (AF) guidelines recommend flecainide as a first-line rhythm control option in patients without structural heart disease. While there is proven efficacy in clinical trials and guideline support, it is hypothesized that flecainide may be underutilized due to n...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343357/ https://www.ncbi.nlm.nih.gov/pubmed/32633682 http://dx.doi.org/10.1177/1753944720926824 |